0000950142-21-003505.txt : 20211102 0000950142-21-003505.hdr.sgml : 20211102 20211102160627 ACCESSION NUMBER: 0000950142-21-003505 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210716 FILED AS OF DATE: 20211102 DATE AS OF CHANGE: 20211102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Javitt Daniel C. CENTRAL INDEX KEY: 0001864534 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38302 FILM NUMBER: 211371252 MAIL ADDRESS: STREET 1: 1201 NORTH MARKET STREET STREET 2: SUITE 111 CITY: WILMINGTON STATE: DE ZIP: 19801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NRX Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001719406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822844431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1201 N. MARKET STREET STREET 2: SUITE 111 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 484-254-6134 MAIL ADDRESS: STREET 1: 1201 N. MARKET STREET STREET 2: SUITE 111 CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Big Rock Partners Acquisition Corp. DATE OF NAME CHANGE: 20171012 4 1 es210197024_4-javittd.xml OWNERSHIP DOCUMENT X0306 4 2021-07-16 0 0001719406 NRX Pharmaceuticals, Inc. NRXP 0001864534 Javitt Daniel C. C/O NRX PHARMACEUTICALS, INC. 1201 NORTH MARKET STREET, SUITE 111 WILMINGTON DE 19801 0 0 1 0 Common Stock 2021-07-16 4 G 0 434594 D 13537270 I By Glytech LLC Common Stock 2021-07-16 4 G 0 434594 D 13102676 I By Glytech LLC Irrevocable gift by way of transfer to certain trusts established for the benefit of the Reporting Person's immediate family members. Neither the Reporting Person nor Glytech LLC received any compensation in respect of such transfers. Upon completion of such transfers, both the Reporting Person and Glytech LLC ceased to have any beneficial ownership or other interest in the shares subject to the transfers. Held by Glytech, LLC of which the Reporting Person is the sole owner. /s/ Daniel Javitt 2021-11-02